Home
Research Trends
Scientific Articles
Journals
Scientific Journals
Open Access Journals
Journals Search
Contact
Sign Up
Login
Language
English
German
Value in Health
Title
Publication Date
Language
Citations
Universal Health Coverage: A Quest for All Countries But under Threat in Some
2013/01/01
English
73
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measure
2010/12/01
English
72
Economic Costs of Influenza-Related Work Absenteeism
2003/03/01
English
72
Methods for the Collection of Resource Use Data within Clinical Trials: A Systematic Review of Studies Funded by the UK Health Technology Assessment Program
2010/12/01
English
72
Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review
2019/10/01
English
72
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I
2010/01/01
English
72
A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report [1]
2018/02/01
English
71
Ten-Year Survival and Cost Following Breast Cancer Recurrence: Estimates from SEER-Medicare Data
2008/03/01
English
71
Comparison of Different Valuation Methods for Population Health Status Measured by the EQ-5D in Three European Countries
2009/07/01
English
71
Valuation of EQ-5D Health States in Poland: First TTO-Based Social Value Set in Central and Eastern Europe
2010/03/01
English
71
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
2019/01/01
English
71
The Routine Collation of Health Outcomes Data from Hospital Treated Subjects in the Health Outcomes Data Repository (HODaR): Descriptive Analysis from the First 20,000 Subjects
2005/09/01
English
70
An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study
2014/07/01
English
70
Costs of Care for Dementia Patients in Community Setting: An Analysis for Mild and Moderate Disease Stage
2011/09/01
English
70
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations
2007/11/01
English
70
Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective
2016/09/01
English
70
Factors Influencing Cost-Related Nonadherence to Medication in Older Adults: A Conceptually Based Approach
2010/06/01
English
70
Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective
2018/11/01
English
69
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group
2018/05/01
English
69
A Trial-Based Assessment of the Cost-Utility of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Non-Small Cell Lung Cancer
2011/09/01
English
69
Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group
2019/02/01
English
69
Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility
2007/05/01
English
69
Outcome Measurement in Clinical Genetics Services: A Systematic Review of Validated Measures
2008/05/01
English
68
Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy
2012/03/01
English
68
Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations?
2005/01/01
English
68
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group
2020/06/01
English
68
Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes
2017/02/01
English
68
EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom
2018/01/01
English
67
Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force
2017/03/01
English
67
A Review of the Cost of Atrial Fibrillation
2012/03/01
English
67
«
‹ Pervious
Next ›
»